Granzyme A
Aliases: | CTLA3, HFSP |
---|---|
Other: | granzyme A|CTL tryptase|Cytotoxic T-lymphocyte-associated serine esterase-3|Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease)|HF|Hanukah factor serine protease)|cytotoxic T-lymphocyte proteinase 1|fragmentin-1|granzyme 1|granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)|h factor |
Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here is a T cell- and natural killer cell-specific s... see more
Alexa Fluor 700
Common Laser: | 628-640 |
---|---|
Common Filter: | 730/45 |
Excitation Peak: | 702 |
Emission Peak: | 723 |
Alexa Fluor™ 700 (AF700, Alexa 700) has an excitation peak at 702 nm and an emission peak at 723 nm, and is spectrally similar to iFluor® 680 (ATT Bioquest) and iFluor® 700 (ATT Bioquest). Alexa 700 is commonly used in Flow Cytometry and is similar in size, brightness and application to iFluor® 700 and Vio® R720.
Popular Granzyme A Alexa Fluor 700 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
IC29051N |
Isotype Ctrl | Granzyme A Human |
Mouse IgG2b 356412 |
100 μg $359 |
Details | |
BioLegend 507210 |
ICS | Granzyme A Human |
Mouse IgG1 κ CB9 |
100 μg $265 |
Details | |
BioLegend 507209 |
Granzyme A Human |
Mouse IgG1 κ CB9 |
25 μg $105 |
Details | ||
Novus Biologicals NBP3-14619AF700 |
FC,ICC, IF | Granzyme A Human |
Mouse IgG1 κ CB9 |
100 μl $377 |
Details | |
Sony 3136050 |
FC | Granzyme A Human |
Mouse IgG1 κ CB9 |
100 μg $260 |
Details | |
R&D Systems IC29051N-100UG |
ICS | Granzyme A Human |
Mouse IgG2b 356412 |
100 μg $388 |
Details | |
Browse Granzyme A / Alexa Fluor 700 antibodies. |